Pancreatic Cancer Research

ResearcherKyoto UniversityActive in the last 2 years

Masahiro Hiraoka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7639-569X; OpenAlex author ID A5015259799. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2011: 1 paper · 2012: 3 papers · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 3 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 14

  1. Multi-Institutional Phase II Study on the Efficacy and Safety of Dynamic Tumor-Tracking, Moderately Hypofractionated Intensity-Modulated Radiotherapy in Patien… First author DOI 10.1002/cam4.70648↗
  2. Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer. First author DOI 10.1038/s41598-018-35402-7↗
  3. Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1186/s13014-018-1063-5↗
  4. HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog. Co-author DOI 10.18632/oncotarget.24156↗
  5. Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer. Last author DOI 10.1016/j.ijrobp.2015.12.362↗
  6. Comparative evaluation of respiratory-gated and ungated FDG-PET for target volume definition in radiotherapy treatment planning for pancreatic cancer. Last author DOI 10.1016/j.radonc.2016.07.012↗
  7. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Last author DOI 10.1016/j.pan.2015.09.016↗
  8. Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable progn… Last author DOI 10.1007/s00066-014-0610-8↗
  9. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose… Last author DOI 10.1118/1.4773033↗
  10. Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a… Last author DOI 10.1120/jacmp.v14i5.4252↗
  11. Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer. Last author DOI 10.1016/j.ijrobp.2011.01.050↗
  12. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer pat… Last author DOI 10.1016/j.ijrobp.2011.12.026↗
  13. Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer. Last author DOI 10.1118/1.3668314↗
  14. Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. Last author DOI 10.1097/coc.0b013e3181c4c7a8↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takashi Mizowaki · 9 shared papers, 2012–2025 · strength 0.64
  2. Mitsuhiro Nakamura · 7 shared papers, 2012–2025 · strength 0.49
  3. Michio Yoshimura · 4 shared papers, 2014–2025 · strength 0.45
  4. Akira Nakamura · 9 shared papers, 2012–2018 · strength 0.39
  5. Keiko Shibuya · 9 shared papers, 2011–2018 · strength 0.36
  6. Katsuyuki Karasawa · 1 shared paper, 2025 · strength 0.25
  7. Takahiro Kishi · 3 shared papers, 2015–2018 · strength 0.18
  8. Kyoichi Takaori · 3 shared papers, 2014–2018 · strength 0.16
  9. Yökö Gotö · 2 shared papers, 2018 · strength 0.14
  10. Masashi Kanai · 2 shared papers, 2015–2018 · strength 0.12
  11. Akira Nakamura · 2 shared papers, 2011–2018 · strength 0.10
  12. Hiroshi Harada · 1 shared paper, 2018 · strength 0.09
  13. Tomohiro Katagiri · 1 shared paper, 2018 · strength 0.09
  14. Ryo Ashida · 1 shared paper, 2018 · strength 0.07
  15. Toshihiko Masui · 1 shared paper, 2018 · strength 0.07
  16. Yuzo Kodama · 1 shared paper, 2018 · strength 0.07
  17. Kaori Togashi · 1 shared paper, 2016 · strength 0.06
  18. Yuzo Kodama · 1 shared paper, 2015 · strength 0.05
  19. Shinji Üemoto · 1 shared paper, 2014 · strength 0.04
  20. Shinichi Ohkawa · 1 shared paper, 2016 · strength 0.04
  21. Taketo Yamaguchi · 1 shared paper, 2016 · strength 0.04
  22. Masayuki Otsuka · 1 shared paper, 2016 · strength 0.04
  23. Takehide Asano · 1 shared paper, 2016 · strength 0.04
  24. Hiroshi Honda · 1 shared paper, 2016 · strength 0.04
  25. Hirohiko Tsujii · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.